Last reviewed · How we verify
General anesthesia with propofol or sevoflurane — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
General anesthesia with propofol or sevoflurane (General anesthesia with propofol or sevoflurane) — Centre Cardiologique du Nord.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| General anesthesia with propofol or sevoflurane TARGET | General anesthesia with propofol or sevoflurane | Centre Cardiologique du Nord | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- General anesthesia with propofol or sevoflurane CI watch — RSS
- General anesthesia with propofol or sevoflurane CI watch — Atom
- General anesthesia with propofol or sevoflurane CI watch — JSON
- General anesthesia with propofol or sevoflurane alone — RSS
Cite this brief
Drug Landscape (2026). General anesthesia with propofol or sevoflurane — Competitive Intelligence Brief. https://druglandscape.com/ci/general-anesthesia-with-propofol-or-sevoflurane. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab